Daniel Lazzareschi Selected Research

Ertapenem (Invanz)

4/2013	T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam.
4/2011	A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Lazzareschi Research Topics

Disease

2	Acute Cholecystitis 01/2014 - 10/2013
2	Intraabdominal Infections 04/2013 - 04/2011
2	Peritonitis 04/2013 - 04/2011
2	Infections 07/2011 - 04/2011
1	Hypotension (Low Blood Pressure) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Cystic Fibrosis (Mucoviscidosis) 11/2015
1	Peritoneal Neoplasms 03/2015
1	Neoplasms (Cancer) 01/2012
1	Cystic Mesothelioma 01/2012
1	Communicable Diseases (Infectious Diseases) 04/2011

Drug/Important Bio-Agent (IBA)

2	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 04/2013 - 04/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2013 - 04/2011
2	Ertapenem (Invanz)FDA Link 04/2013 - 04/2011
1	Crystalloid SolutionsIBA 01/2022
1	CreatinineIBA 01/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022
1	PolymersIBA 11/2015

Therapy/Procedure

3	Therapeutics 04/2013 - 04/2011
2	Laparoscopic Cholecystectomy 01/2014 - 10/2013
1	Cytoreduction Surgical Procedures 03/2015
1	Diathermy 01/2014
1	Length of Stay 10/2013
1	Cholecystectomy 10/2013
1	Hyperthermic Intraperitoneal Chemotherapy 01/2012
1	Prostheses and Implants (Prosthesis) 07/2011